Response to CMA clearance

RNS Number : 1842I
Flutter Entertainment PLC
31 March 2020
 

31 March 2020

 

FOR IMMEDIATE RELEASE  

 

UK Competition and Markets Authority announcement re:

Flutter proposed Combination with The Stars Group Inc.

 

Flutter Entertainment PLC ("Flutter") notes today's announcement from the UK Competition and Markets Authority ("CMA") that it has given unconditional phase one clearance to its proposed combination with The Stars Group Inc.

 

The proposed transaction remains subject to approval by Flutter shareholders at its extraordinary general meeting on 21 April 2020 and by The Stars Group shareholders on 24 April 2020. It also remains conditional on approval from a small number of other regulatory bodies, some of whom have indicated that their usual timeframes may be delayed by the current COVID-19 crisis.

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation EU 596/2016.

 

Welcoming today's announcement, Peter Jackson, Chief Executive, said:

"This morning's announcement from the CMA marks a further important milestone in the process towards completion of our proposed combination with The Stars Group. We continue to work with the remaining international regulatory authorities to obtain the last of the outstanding approvals. Separately last week we published the necessary documentation ahead of the shareholder votes in April and we continue to make good progress in our post-completion planning."

 

 

Investor relations

David Jennings, Corporate Finance & Investor Relations    + 353 87 951 3560

Ciara O'Mullane, Investor Relations  + 353 87 947 7862

Liam Kealy, Investor Relations  + 353 87 665 2014

 

Media

Fi Thorne, Corporate Affairs  + 44 20 8834 6018

James Murgatroyd, Finsbury  + 44 20 7251 3801

Billy Murphy, Drury / Porter Novelli + 353 1 260 5000

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCDFLBXBXLBBBD
UK 100

Latest directors dealings